BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Concord Biotech Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543960
ISIN Demat
INE338H01029
Book Value (Rs)
174.4719509
NSE Symbol
CONCORDBIO
Divident Yield %
0.72
Market Cap
(Rs In Cr.)
12,751
P/E (TTM)
40.15
EPS (TTM)
30.36
Face Value
(Rs)
1
Back
Concord Biotech consolidated net profit declines 33.59% in the September 2025 quarter
15-Nov-25   Hrs IST

Net profit of Concord Biotech declined 33.59% to Rs 63.58 crore in the quarter ended September 2025 as against Rs 95.74 crore during the previous quarter ended September 2024. Sales declined 20.35% to Rs 247.06 crore in the quarter ended September 2025 as against Rs 310.18 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales247.06310.18 -20
OPM %35.8243.11 -
PBDT104.08143.65 -28
PBT85.68130.34 -34
NP63.5895.74 -34

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)